A clinical study of the role of â?? Yogsaramrutam Churnaâ?? (Chakradutta) with â??Kaishor Guggulâ?? in the management of joint pain related to Gout.

An Open Randomized Comparative clinical study of efficacy of â?? Yogsaramrutam Churnaâ?? (Chakradutta) with â??Kaishor Guggulâ?? in the management of Vatrakta with special reference to Gout.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/04/051579

Enrollment

Registered

2023-04-13

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M255- Pain in joint

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.All genders will be included. 2.Age group -30 year to 60 year 3.All the patients clinically diagnosed as Vatarakta (gout) 4.Hyperuricaemic patients with symptoms of gout. 5.Patients having uric acid level less than 12mg/dl

Exclusion criteria

Exclusion criteria: 1.Patients suffering from secondary gout 2.Patients with renal failure. 3.Pregnant & lactating mothers. 4.Patients having k/c/o DM,HIV and Leprosy. 5.History of MI and Kochâ??s (Upto 6 months prior to 1st visit ) 6.Patients diagnosed with tuberculous arthritis, destructive artropathies, osteoarthritis, Aamvata . 7.Patients having Uric acid level more than 12mg/dl.

Design outcomes

Primary

Measure	Time frame
To check the improvement in symptoms according to the subjective and objective criteria as mentioned in the synopsis.Timepoint: 7th day, 14th day and 28th day.	—

Secondary

Measure	Time frame
To check the safety of the drug.Timepoint: 7th day, 14th day and 28th day.	—

Countries

India

Contacts

Public ContactDr Hemant Paradkar

APMs Ayuved Mahavidyalaya, Sion.

hemant.paradkar@gmail.com9702029315

Outcome results